Medicon Valley Alliance (MVA) has signed an important collaboration agreement with Japan Bioindustry Association (JBA). The agreement, secured through the MVA Ambassador Program, creates new opportunities for Danish-Swedish life science in Japan and is expected to strengthen Japan’s already substantial interest in Medicon Valley.
Second Largest Market
- Japan is the world’s second largest market for pharmaceuticals and medical equipment, only surpassed by the U.S. Therefore, it is significant that we have achieved an extensive Japanese interest in Medicon Valley. It also creates new opportunities in Japan for the businesses and universities in our region. Japan is a market, which demands patience and a long-term strategy, but it is not an insurmountable challenge, says Charlotte Ahlgren Moritz, Vice President of MVA and Head of the MVA Ambassador Program.
With the new collaboration agreement, MVA and JBA will aim to establish partnerships between the industry and universities in Medicon Valley and those in Japan. The agreement includes all aspects of research, development and production as well as commercialization.
Great Interest in Medicon Valley
The collaboration is being established at a time when several large Japanese pharmaceutical companies are already showing interest in life science in the Øresund region.
- The Japanese pharmaceutical companies have been focusing on the Medicon Valley region’s biotech and medical equipment companies for quite a while. We are also experiencing a great interest in innovation at an early stage at the universities in Medicon Valley, says Thomas Jonsson, who has spent the last five years as MVA Ambassador in Japan.
Japanese companies such as Astellas, DaiichiSankyo, Terumo, Yakult, MitsubishiTanabe, Shionogi, Ono, Panasonic, Eisai, and Olympus have shown great interest in Medicon Valley and as a result, the MVA Ambassador Program has arranged several Japanese visits to the region.
Senior Coordinating Manager, MVA Ambassador Program
Phone: (T) +45 3287 8009 (M) +45 23715605